Yoo J K, Seikaly H, Calhoun K H
Department of Otolaryngology, University of Texas Medical Branch, Galveston 77550-0521, USA.
Laryngoscope. 1997 Jan;107(1):40-3. doi: 10.1097/00005537-199701000-00010.
Use of sympathomimetic topical nasal decongestants to treat nasal obstruction is usually restricted to 3 to 5 days to avoid potential rebound swelling (rhinitis medicamentosa). In this study, 10 healthy volunteers used oxymetazoline (long-acting topical nasal decongestant) nightly for 4 weeks. Subjects who used antihistamines, oral or topical decongestants, or systemic steroids or who had active sinusitis were excluded from the study. Weekly history, physical examination, and anterior rhinomanometry revealed no adverse effects. Eight (80%) subjects developed nightly nasal obstruction a few hours before the evening dose; the obstruction resolved within 48 hours if no more decongestant was used. All subjects remained responsive to oxymetazoline 4 weeks and 8 weeks after the study began. This finding suggests that long-acting decongestants may be safely used for longer than the recommended 3 to 5 days without adverse effects if used once nightly.
使用拟交感神经局部鼻减充血剂治疗鼻塞通常限制在3至5天,以避免潜在的反弹性肿胀(药物性鼻炎)。在本研究中,10名健康志愿者每晚使用羟甲唑啉(长效局部鼻减充血剂),持续4周。使用抗组胺药、口服或局部减充血剂、全身用类固醇或患有活动性鼻窦炎的受试者被排除在研究之外。每周的病史、体格检查和前鼻测压均未发现不良反应。8名(80%)受试者在晚间用药前数小时出现夜间鼻塞;如果不再使用减充血剂,鼻塞在48小时内缓解。在研究开始4周和8周后,所有受试者对羟甲唑啉仍有反应。这一发现表明,如果每晚使用一次,长效减充血剂可以安全地使用超过推荐时间3至5天而无不良反应。